83 Biggest Movers From Yesterday
Gainers
Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results.
Evofem Biosciences Q1 Sales $4.30M Beat $4.15M Estimate
Evofem Biosciences (NASDAQ:EVFM) reported quarterly sales of $4.30 million which beat the analyst consensus estimate of $4.15 million by 3.61 percent. This is a 289.14 percent increase over sales of $1.10 million the
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
20 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares rose 38% to $3.69 in pre-market trading. Sonoma Pharmaceuticals and MicroSafe Group DMCC reported EPA approval for Nanocyn hospital-grade disinfectant in the U.S.
Evofem Biosciences Enters Agreement With VitaCare Prescription Services To Provide Enhanced ‘White Glove’ Support Services To Women Prescribed Phexxi
Evofem Anticipates Greater Numbers of Phexxi® (lactic acid, citric acid, potassium bitartrate) Prescriptions Filled as a Result of VitaCare Agreement
New Agreement Provides More Efficient Patient Follow-Up
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Stocks That Hit 52-Week Lows On Friday
During Friday's morning session, 234 stocks hit new 52-week lows.
Evofem Biosciences Highlights Presentation Of Encore Data In Sexually Transmitted Infections Impacting Women During Academy Of Managed Care Pharmacy Meeting
Phase 2B/3 AMPREVENCE Clinical Trial Concluded with Women Experiencing a 50 Percent Risk Reduction in Chlamydia Trachomatis (chlamydia) and a 78 Percent Risk Reduction in Neisseria Gonorrhoeae (gonorrhea) using EVO100
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
Puma Biotechnology (NASDAQ:PBYI) shares moved upwards by 12.0% to $2.61 during Thursday's after-market session. The company's market cap stands at $106.7 million. As per the press release, Q4 earnings came out today.